192 related articles for article (PubMed ID: 37158258)
21. Modification of enhancer chromatin: what, how, and why?
Calo E; Wysocka J
Mol Cell; 2013 Mar; 49(5):825-37. PubMed ID: 23473601
[TBL] [Abstract][Full Text] [Related]
22. Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.
Dorighi KM; Swigut T; Henriques T; Bhanu NV; Scruggs BS; Nady N; Still CD; Garcia BA; Adelman K; Wysocka J
Mol Cell; 2017 May; 66(4):568-576.e4. PubMed ID: 28483418
[TBL] [Abstract][Full Text] [Related]
23. Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.
Zhao MT; Shao NY; Hu S; Ma N; Srinivasan R; Jahanbani F; Lee J; Zhang SL; Snyder MP; Wu JC
Circ Res; 2017 Nov; 121(11):1237-1250. PubMed ID: 29030344
[TBL] [Abstract][Full Text] [Related]
24. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
[TBL] [Abstract][Full Text] [Related]
25. Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.
Rickels R; Herz HM; Sze CC; Cao K; Morgan MA; Collings CK; Gause M; Takahashi YH; Wang L; Rendleman EJ; Marshall SA; Krueger A; Bartom ET; Piunti A; Smith ER; Abshiru NA; Kelleher NL; Dorsett D; Shilatifard A
Nat Genet; 2017 Nov; 49(11):1647-1653. PubMed ID: 28967912
[TBL] [Abstract][Full Text] [Related]
26. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
[TBL] [Abstract][Full Text] [Related]
27. Regulation Network of Colorectal-Cancer-Specific Enhancers in the Progression of Colorectal Cancer.
Chen B; Ma Y; Bi J; Wang W; He A; Su G; Zhao Z; Shi J; Zhang L
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361106
[TBL] [Abstract][Full Text] [Related]
28. Bidirectional transcription initiation marks accessible chromatin and is not specific to enhancers.
Young RS; Kumar Y; Bickmore WA; Taylor MS
Genome Biol; 2017 Dec; 18(1):242. PubMed ID: 29284524
[TBL] [Abstract][Full Text] [Related]
29. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.
Lin-Shiao E; Lan Y; Coradin M; Anderson A; Donahue G; Simpson CL; Sen P; Saffie R; Busino L; Garcia BA; Berger SL; Capell BC
Genes Dev; 2018 Jan; 32(2):181-193. PubMed ID: 29440247
[TBL] [Abstract][Full Text] [Related]
30. Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.
Orouji E; Raman AT; Singh AK; Sorokin A; Arslan E; Ghosh AK; Schulz J; Terranova C; Jiang S; Tang M; Maitituoheti M; Callahan SC; Barrodia P; Tomczak K; Jiang Y; Jiang Z; Davis JS; Ghosh S; Lee HM; Reyes-Uribe L; Chang K; Liu Y; Chen H; Azhdarinia A; Morris J; Vilar E; Carmon KS; Kopetz SE; Rai K
Gut; 2022 May; 71(5):938-949. PubMed ID: 34059508
[TBL] [Abstract][Full Text] [Related]
31. Epigenome overlap measure (EPOM) for comparing tissue/cell types based on chromatin states.
Li WV; Razaee ZS; Li JJ
BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):10. PubMed ID: 26817822
[TBL] [Abstract][Full Text] [Related]
32. Chromatin opening and stable perturbation of core histone:DNA contacts by FoxO1.
Hatta M; Cirillo LA
J Biol Chem; 2007 Dec; 282(49):35583-93. PubMed ID: 17923482
[TBL] [Abstract][Full Text] [Related]
33. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
[TBL] [Abstract][Full Text] [Related]
34. A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.
Cheng J; Blum R; Bowman C; Hu D; Shilatifard A; Shen S; Dynlacht BD
Mol Cell; 2014 Mar; 53(6):979-92. PubMed ID: 24656132
[TBL] [Abstract][Full Text] [Related]
35. Histone H3 lysine 4 methyltransferase KMT2D.
Froimchuk E; Jang Y; Ge K
Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.
Lo PK; Lee JS; Chen H; Reisman D; Berger FG; Sukumar S
Exp Mol Pathol; 2013 Feb; 94(1):262-9. PubMed ID: 23103611
[TBL] [Abstract][Full Text] [Related]
37. Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin Interactions.
Cao F; Fang Y; Tan HK; Goh Y; Choy JYH; Koh BTH; Hao Tan J; Bertin N; Ramadass A; Hunter E; Green J; Salter M; Akoulitchev A; Wang W; Chng WJ; Tenen DG; Fullwood MJ
Sci Rep; 2017 May; 7(1):2186. PubMed ID: 28526829
[TBL] [Abstract][Full Text] [Related]
38. Enhancers: emerging roles in cell fate specification.
Ong CT; Corces VG
EMBO Rep; 2012 Apr; 13(5):423-30. PubMed ID: 22491032
[TBL] [Abstract][Full Text] [Related]
39. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
[TBL] [Abstract][Full Text] [Related]
40. MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer.
Sze CC; Shilatifard A
Cold Spring Harb Perspect Med; 2016 Nov; 6(11):. PubMed ID: 27638352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
